Both of these groups have done painstaking searches for such autoantibodies - the first finding candidates targeting skin and epithelial tissue, the second (looking closely at patients with neurological and cognitive symptoms) targeting neural and endocrine tissues. It’s believed that the skin/epithelial autoantibodies may well be targeting nerve endings in those tissues, so there could be an overall neurological component to Long Covid in general.